nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxcarbazepine—ALB—acquired immunodeficiency syndrome	0.282	1	CbGaD
Oxcarbazepine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0316	0.06	CbGbCtD
Oxcarbazepine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0286	0.0542	CbGbCtD
Oxcarbazepine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0286	0.0542	CbGbCtD
Oxcarbazepine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0271	0.0514	CbGbCtD
Oxcarbazepine—ALB—Saquinavir—acquired immunodeficiency syndrome	0.027	0.0511	CbGbCtD
Oxcarbazepine—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0259	0.049	CbGbCtD
Oxcarbazepine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0255	0.0484	CbGbCtD
Oxcarbazepine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0247	0.0468	CbGbCtD
Oxcarbazepine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.024	0.0454	CbGbCtD
Oxcarbazepine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0231	0.0437	CbGbCtD
Oxcarbazepine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0231	0.0437	CbGbCtD
Oxcarbazepine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0217	0.0411	CbGbCtD
Oxcarbazepine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0217	0.0411	CbGbCtD
Oxcarbazepine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0199	0.0378	CbGbCtD
Oxcarbazepine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0193	0.0367	CbGbCtD
Oxcarbazepine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0175	0.0332	CbGbCtD
Oxcarbazepine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0175	0.0332	CbGbCtD
Oxcarbazepine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0168	0.0318	CbGbCtD
Oxcarbazepine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0131	0.0249	CbGbCtD
Oxcarbazepine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0123	0.0234	CbGbCtD
Oxcarbazepine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0123	0.0234	CbGbCtD
Oxcarbazepine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0112	0.0211	CbGbCtD
Oxcarbazepine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0112	0.0211	CbGbCtD
Oxcarbazepine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00963	0.0183	CbGbCtD
Oxcarbazepine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00935	0.0177	CbGbCtD
Oxcarbazepine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00845	0.016	CbGbCtD
Oxcarbazepine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00845	0.016	CbGbCtD
Oxcarbazepine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0081	0.0154	CbGbCtD
Oxcarbazepine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000276	0.113	CbGeAlD
Oxcarbazepine—Magnesium salicylate—ALB—acquired immunodeficiency syndrome	0.00027	0.302	CrCbGaD
Oxcarbazepine—Piroxicam—ALB—acquired immunodeficiency syndrome	0.000259	0.29	CrCbGaD
Oxcarbazepine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000218	0.0888	CbGeAlD
Oxcarbazepine—SCN5A—digestive system—acquired immunodeficiency syndrome	0.000165	0.0672	CbGeAlD
Oxcarbazepine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000163	0.0666	CbGeAlD
Oxcarbazepine—SCN5A—blood—acquired immunodeficiency syndrome	0.000157	0.0641	CbGeAlD
Oxcarbazepine—SCN5A—vagina—acquired immunodeficiency syndrome	0.000146	0.0594	CbGeAlD
Oxcarbazepine—Warfarin—ALB—acquired immunodeficiency syndrome	0.000145	0.163	CrCbGaD
Oxcarbazepine—SCN5A—nervous system—acquired immunodeficiency syndrome	0.000127	0.052	CbGeAlD
Oxcarbazepine—SCN5A—central nervous system—acquired immunodeficiency syndrome	0.000123	0.0501	CbGeAlD
Oxcarbazepine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000106	0.0433	CbGeAlD
Oxcarbazepine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000101	0.0413	CbGeAlD
Oxcarbazepine—SCN5A—brain—acquired immunodeficiency syndrome	9.74e-05	0.0397	CbGeAlD
Oxcarbazepine—CYP2C19—vagina—acquired immunodeficiency syndrome	9.38e-05	0.0383	CbGeAlD
Oxcarbazepine—Nortriptyline—ALB—acquired immunodeficiency syndrome	8.94e-05	0.1	CrCbGaD
Oxcarbazepine—CYP3A5—digestive system—acquired immunodeficiency syndrome	8.37e-05	0.0341	CbGeAlD
Oxcarbazepine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	8.03e-05	0.00043	CcSEcCtD
Oxcarbazepine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	8.01e-05	0.000429	CcSEcCtD
Oxcarbazepine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000429	CcSEcCtD
Oxcarbazepine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000429	CcSEcCtD
Oxcarbazepine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	8.01e-05	0.000429	CcSEcCtD
Oxcarbazepine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	7.98e-05	0.000427	CcSEcCtD
Oxcarbazepine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	7.98e-05	0.000427	CcSEcCtD
Oxcarbazepine—CYP3A5—blood—acquired immunodeficiency syndrome	7.97e-05	0.0325	CbGeAlD
Oxcarbazepine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000426	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.95e-05	0.000426	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.93e-05	0.000424	CcSEcCtD
Oxcarbazepine—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.92e-05	0.000424	CcSEcCtD
Oxcarbazepine—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.92e-05	0.000424	CcSEcCtD
Oxcarbazepine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.91e-05	0.000424	CcSEcCtD
Oxcarbazepine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.91e-05	0.000423	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.9e-05	0.000423	CcSEcCtD
Oxcarbazepine—Cough—Saquinavir—acquired immunodeficiency syndrome	7.9e-05	0.000423	CcSEcCtD
Oxcarbazepine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7.89e-05	0.000422	CcSEcCtD
Oxcarbazepine—Pain—Indinavir—acquired immunodeficiency syndrome	7.85e-05	0.00042	CcSEcCtD
Oxcarbazepine—Constipation—Indinavir—acquired immunodeficiency syndrome	7.85e-05	0.00042	CcSEcCtD
Oxcarbazepine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	7.85e-05	0.00042	CcSEcCtD
Oxcarbazepine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	7.84e-05	0.00042	CcSEcCtD
Oxcarbazepine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	7.84e-05	0.00042	CcSEcCtD
Oxcarbazepine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	7.83e-05	0.000419	CcSEcCtD
Oxcarbazepine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.82e-05	0.000418	CcSEcCtD
Oxcarbazepine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.000418	CcSEcCtD
Oxcarbazepine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.81e-05	0.000418	CcSEcCtD
Oxcarbazepine—ALB—brain—acquired immunodeficiency syndrome	7.8e-05	0.0318	CbGeAlD
Oxcarbazepine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.8e-05	0.000417	CcSEcCtD
Oxcarbazepine—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.79e-05	0.000417	CcSEcCtD
Oxcarbazepine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.77e-05	0.000416	CcSEcCtD
Oxcarbazepine—Nausea—Didanosine—acquired immunodeficiency syndrome	7.77e-05	0.000416	CcSEcCtD
Oxcarbazepine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.76e-05	0.000415	CcSEcCtD
Oxcarbazepine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	7.76e-05	0.000415	CcSEcCtD
Oxcarbazepine—Syncope—Lamivudine—acquired immunodeficiency syndrome	7.75e-05	0.000415	CcSEcCtD
Oxcarbazepine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.000414	CcSEcCtD
Oxcarbazepine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.74e-05	0.000414	CcSEcCtD
Oxcarbazepine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.73e-05	0.000414	CcSEcCtD
Oxcarbazepine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.71e-05	0.000413	CcSEcCtD
Oxcarbazepine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.000413	CcSEcCtD
Oxcarbazepine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.000413	CcSEcCtD
Oxcarbazepine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	7.71e-05	0.000413	CcSEcCtD
Oxcarbazepine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.68e-05	0.000411	CcSEcCtD
Oxcarbazepine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.66e-05	0.00041	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	7.65e-05	0.00041	CcSEcCtD
Oxcarbazepine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.64e-05	0.000409	CcSEcCtD
Oxcarbazepine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.000408	CcSEcCtD
Oxcarbazepine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000406	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.57e-05	0.000405	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.56e-05	0.000405	CcSEcCtD
Oxcarbazepine—Shock—Ritonavir—acquired immunodeficiency syndrome	7.55e-05	0.000404	CcSEcCtD
Oxcarbazepine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.54e-05	0.000404	CcSEcCtD
Oxcarbazepine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	7.54e-05	0.000403	CcSEcCtD
Oxcarbazepine—Cough—Lamivudine—acquired immunodeficiency syndrome	7.54e-05	0.000403	CcSEcCtD
Oxcarbazepine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.54e-05	0.000403	CcSEcCtD
Oxcarbazepine—ALB—lymph node—acquired immunodeficiency syndrome	7.53e-05	0.0307	CbGeAlD
Oxcarbazepine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	7.53e-05	0.000403	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.52e-05	0.000402	CcSEcCtD
Oxcarbazepine—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.51e-05	0.000402	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.51e-05	0.000402	CcSEcCtD
Oxcarbazepine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	7.51e-05	0.000402	CcSEcCtD
Oxcarbazepine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7.49e-05	0.000401	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.49e-05	0.000401	CcSEcCtD
Oxcarbazepine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.48e-05	0.0004	CcSEcCtD
Oxcarbazepine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.48e-05	0.0004	CcSEcCtD
Oxcarbazepine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.48e-05	0.0004	CcSEcCtD
Oxcarbazepine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.46e-05	0.000399	CcSEcCtD
Oxcarbazepine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.000399	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.42e-05	0.000397	CcSEcCtD
Oxcarbazepine—Pain—Efavirenz—acquired immunodeficiency syndrome	7.42e-05	0.000397	CcSEcCtD
Oxcarbazepine—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.42e-05	0.000397	CcSEcCtD
Oxcarbazepine—Rash—Nevirapine—acquired immunodeficiency syndrome	7.42e-05	0.000397	CcSEcCtD
Oxcarbazepine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.41e-05	0.000397	CcSEcCtD
Oxcarbazepine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.4e-05	0.000396	CcSEcCtD
Oxcarbazepine—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.4e-05	0.000396	CcSEcCtD
Oxcarbazepine—CYP3A5—vagina—acquired immunodeficiency syndrome	7.39e-05	0.0301	CbGeAlD
Oxcarbazepine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.38e-05	0.000395	CcSEcCtD
Oxcarbazepine—Headache—Nevirapine—acquired immunodeficiency syndrome	7.37e-05	0.000394	CcSEcCtD
Oxcarbazepine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000394	CcSEcCtD
Oxcarbazepine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000394	CcSEcCtD
Oxcarbazepine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	7.35e-05	0.000394	CcSEcCtD
Oxcarbazepine—Infection—Saquinavir—acquired immunodeficiency syndrome	7.34e-05	0.000393	CcSEcCtD
Oxcarbazepine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.33e-05	0.000392	CcSEcCtD
Oxcarbazepine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.32e-05	0.000392	CcSEcCtD
Oxcarbazepine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.31e-05	0.000391	CcSEcCtD
Oxcarbazepine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.3e-05	0.000391	CcSEcCtD
Oxcarbazepine—Urticaria—Indinavir—acquired immunodeficiency syndrome	7.3e-05	0.00039	CcSEcCtD
Oxcarbazepine—Shock—Saquinavir—acquired immunodeficiency syndrome	7.27e-05	0.000389	CcSEcCtD
Oxcarbazepine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000389	CcSEcCtD
Oxcarbazepine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.000389	CcSEcCtD
Oxcarbazepine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.26e-05	0.000389	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.25e-05	0.000388	CcSEcCtD
Oxcarbazepine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.25e-05	0.000388	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.23e-05	0.000387	CcSEcCtD
Oxcarbazepine—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.22e-05	0.000387	CcSEcCtD
Oxcarbazepine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.22e-05	0.000386	CcSEcCtD
Oxcarbazepine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	7.19e-05	0.000385	CcSEcCtD
Oxcarbazepine—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.19e-05	0.000385	CcSEcCtD
Oxcarbazepine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.18e-05	0.000384	CcSEcCtD
Oxcarbazepine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.18e-05	0.000384	CcSEcCtD
Oxcarbazepine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	7.17e-05	0.000384	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.17e-05	0.000384	CcSEcCtD
Oxcarbazepine—Rash—Stavudine—acquired immunodeficiency syndrome	7.16e-05	0.000383	CcSEcCtD
Oxcarbazepine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.16e-05	0.000383	CcSEcCtD
Oxcarbazepine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.16e-05	0.000383	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.15e-05	0.000383	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	7.14e-05	0.000382	CcSEcCtD
Oxcarbazepine—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.14e-05	0.000382	CcSEcCtD
Oxcarbazepine—Headache—Stavudine—acquired immunodeficiency syndrome	7.12e-05	0.000381	CcSEcCtD
Oxcarbazepine—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.12e-05	0.000381	CcSEcCtD
Oxcarbazepine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.00038	CcSEcCtD
Oxcarbazepine—Pain—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.00038	CcSEcCtD
Oxcarbazepine—Constipation—Delavirdine—acquired immunodeficiency syndrome	7.1e-05	0.00038	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7.09e-05	0.00038	CcSEcCtD
Oxcarbazepine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7.08e-05	0.000379	CcSEcCtD
Oxcarbazepine—Rash—Abacavir—acquired immunodeficiency syndrome	7.06e-05	0.000378	CcSEcCtD
Oxcarbazepine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	7.05e-05	0.000377	CcSEcCtD
Oxcarbazepine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	7.05e-05	0.000377	CcSEcCtD
Oxcarbazepine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	7.04e-05	0.000377	CcSEcCtD
Oxcarbazepine—Headache—Abacavir—acquired immunodeficiency syndrome	7.01e-05	0.000375	CcSEcCtD
Oxcarbazepine—Infection—Lamivudine—acquired immunodeficiency syndrome	7e-05	0.000375	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.99e-05	0.000374	CcSEcCtD
Oxcarbazepine—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.99e-05	0.000374	CcSEcCtD
Oxcarbazepine—CYP3A5—lung—acquired immunodeficiency syndrome	6.99e-05	0.0285	CbGeAlD
Oxcarbazepine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.99e-05	0.000374	CcSEcCtD
Oxcarbazepine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.94e-05	0.000372	CcSEcCtD
Oxcarbazepine—Shock—Lamivudine—acquired immunodeficiency syndrome	6.94e-05	0.000371	CcSEcCtD
Oxcarbazepine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	6.91e-05	0.00037	CcSEcCtD
Oxcarbazepine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.9e-05	0.00037	CcSEcCtD
Oxcarbazepine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.9e-05	0.000369	CcSEcCtD
Oxcarbazepine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.89e-05	0.000369	CcSEcCtD
Oxcarbazepine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000367	CcSEcCtD
Oxcarbazepine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000367	CcSEcCtD
Oxcarbazepine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.85e-05	0.000366	CcSEcCtD
Oxcarbazepine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.84e-05	0.000366	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.84e-05	0.000366	CcSEcCtD
Oxcarbazepine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.82e-05	0.000365	CcSEcCtD
Oxcarbazepine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.81e-05	0.000365	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.79e-05	0.000363	CcSEcCtD
Oxcarbazepine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.77e-05	0.000362	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.77e-05	0.000362	CcSEcCtD
Oxcarbazepine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000362	CcSEcCtD
Oxcarbazepine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.76e-05	0.000362	CcSEcCtD
Oxcarbazepine—Diazepam—ALB—acquired immunodeficiency syndrome	6.76e-05	0.0756	CrCbGaD
Oxcarbazepine—Nausea—Stavudine—acquired immunodeficiency syndrome	6.75e-05	0.000361	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.73e-05	0.00036	CcSEcCtD
Oxcarbazepine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.72e-05	0.00036	CcSEcCtD
Oxcarbazepine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	6.68e-05	0.000358	CcSEcCtD
Oxcarbazepine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.67e-05	0.000357	CcSEcCtD
Oxcarbazepine—Nausea—Abacavir—acquired immunodeficiency syndrome	6.65e-05	0.000356	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.63e-05	0.000355	CcSEcCtD
Oxcarbazepine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.62e-05	0.000354	CcSEcCtD
Oxcarbazepine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	6.59e-05	0.000353	CcSEcCtD
Oxcarbazepine—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.59e-05	0.000353	CcSEcCtD
Oxcarbazepine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000353	CcSEcCtD
Oxcarbazepine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.59e-05	0.000353	CcSEcCtD
Oxcarbazepine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.57e-05	0.000352	CcSEcCtD
Oxcarbazepine—Pain—Ritonavir—acquired immunodeficiency syndrome	6.56e-05	0.000351	CcSEcCtD
Oxcarbazepine—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.56e-05	0.000351	CcSEcCtD
Oxcarbazepine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.56e-05	0.000351	CcSEcCtD
Oxcarbazepine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.56e-05	0.000351	CcSEcCtD
Oxcarbazepine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.53e-05	0.000349	CcSEcCtD
Oxcarbazepine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.5e-05	0.000348	CcSEcCtD
Oxcarbazepine—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.5e-05	0.000348	CcSEcCtD
Oxcarbazepine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.42e-05	0.000344	CcSEcCtD
Oxcarbazepine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.42e-05	0.000344	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.39e-05	0.000342	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.38e-05	0.000341	CcSEcCtD
Oxcarbazepine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.38e-05	0.000341	CcSEcCtD
Oxcarbazepine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.37e-05	0.000341	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.33e-05	0.000339	CcSEcCtD
Oxcarbazepine—Pain—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000338	CcSEcCtD
Oxcarbazepine—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.32e-05	0.000338	CcSEcCtD
Oxcarbazepine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000336	CcSEcCtD
Oxcarbazepine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.28e-05	0.000336	CcSEcCtD
Oxcarbazepine—CYP3A4—digestive system—acquired immunodeficiency syndrome	6.28e-05	0.0256	CbGeAlD
Oxcarbazepine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.28e-05	0.000336	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.28e-05	0.000336	CcSEcCtD
Oxcarbazepine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.27e-05	0.000335	CcSEcCtD
Oxcarbazepine—Rash—Zidovudine—acquired immunodeficiency syndrome	6.23e-05	0.000333	CcSEcCtD
Oxcarbazepine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.23e-05	0.000333	CcSEcCtD
Oxcarbazepine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.22e-05	0.000333	CcSEcCtD
Oxcarbazepine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.2e-05	0.000332	CcSEcCtD
Oxcarbazepine—Amitriptyline—ALB—acquired immunodeficiency syndrome	6.2e-05	0.0694	CrCbGaD
Oxcarbazepine—Headache—Zidovudine—acquired immunodeficiency syndrome	6.19e-05	0.000331	CcSEcCtD
Oxcarbazepine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.14e-05	0.000329	CcSEcCtD
Oxcarbazepine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.13e-05	0.000328	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	6.12e-05	0.000327	CcSEcCtD
Oxcarbazepine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.000326	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6.09e-05	0.000326	CcSEcCtD
Oxcarbazepine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.09e-05	0.000326	CcSEcCtD
Oxcarbazepine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.08e-05	0.000325	CcSEcCtD
Oxcarbazepine—Dizziness—Indinavir—acquired immunodeficiency syndrome	6.07e-05	0.000325	CcSEcCtD
Oxcarbazepine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000325	CcSEcCtD
Oxcarbazepine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000325	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	6.04e-05	0.000323	CcSEcCtD
Oxcarbazepine—Constipation—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000323	CcSEcCtD
Oxcarbazepine—Pain—Lamivudine—acquired immunodeficiency syndrome	6.03e-05	0.000323	CcSEcCtD
Oxcarbazepine—CYP3A4—blood—acquired immunodeficiency syndrome	5.98e-05	0.0244	CbGeAlD
Oxcarbazepine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.96e-05	0.000319	CcSEcCtD
Oxcarbazepine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.94e-05	0.000318	CcSEcCtD
Oxcarbazepine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.87e-05	0.000314	CcSEcCtD
Oxcarbazepine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000314	CcSEcCtD
Oxcarbazepine—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.87e-05	0.000314	CcSEcCtD
Oxcarbazepine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000313	CcSEcCtD
Oxcarbazepine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000313	CcSEcCtD
Oxcarbazepine—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.84e-05	0.000312	CcSEcCtD
Oxcarbazepine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.81e-05	0.000311	CcSEcCtD
Oxcarbazepine—Rash—Indinavir—acquired immunodeficiency syndrome	5.79e-05	0.00031	CcSEcCtD
Oxcarbazepine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.78e-05	0.00031	CcSEcCtD
Oxcarbazepine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.76e-05	0.000308	CcSEcCtD
Oxcarbazepine—Headache—Indinavir—acquired immunodeficiency syndrome	5.75e-05	0.000308	CcSEcCtD
Oxcarbazepine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.74e-05	0.000307	CcSEcCtD
Oxcarbazepine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.68e-05	0.000304	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.66e-05	0.000303	CcSEcCtD
Oxcarbazepine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.0003	CcSEcCtD
Oxcarbazepine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.000298	CcSEcCtD
Oxcarbazepine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.57e-05	0.000298	CcSEcCtD
Oxcarbazepine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.52e-05	0.000295	CcSEcCtD
Oxcarbazepine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.51e-05	0.000295	CcSEcCtD
Oxcarbazepine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.49e-05	0.000294	CcSEcCtD
Oxcarbazepine—Rash—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.000293	CcSEcCtD
Oxcarbazepine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.47e-05	0.000293	CcSEcCtD
Oxcarbazepine—Nausea—Indinavir—acquired immunodeficiency syndrome	5.45e-05	0.000292	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.44e-05	0.000291	CcSEcCtD
Oxcarbazepine—Headache—Efavirenz—acquired immunodeficiency syndrome	5.44e-05	0.000291	CcSEcCtD
Oxcarbazepine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.43e-05	0.000291	CcSEcCtD
Oxcarbazepine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.3e-05	0.000284	CcSEcCtD
Oxcarbazepine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.28e-05	0.000282	CcSEcCtD
Oxcarbazepine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.25e-05	0.000281	CcSEcCtD
Oxcarbazepine—Rash—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.00028	CcSEcCtD
Oxcarbazepine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.23e-05	0.00028	CcSEcCtD
Oxcarbazepine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.23e-05	0.00028	CcSEcCtD
Oxcarbazepine—Headache—Delavirdine—acquired immunodeficiency syndrome	5.2e-05	0.000278	CcSEcCtD
Oxcarbazepine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.19e-05	0.000278	CcSEcCtD
Oxcarbazepine—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.15e-05	0.000276	CcSEcCtD
Oxcarbazepine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.08e-05	0.000272	CcSEcCtD
Oxcarbazepine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5.06e-05	0.000271	CcSEcCtD
Oxcarbazepine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5.06e-05	0.000271	CcSEcCtD
Oxcarbazepine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.99e-05	0.000267	CcSEcCtD
Oxcarbazepine—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.93e-05	0.000264	CcSEcCtD
Oxcarbazepine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.89e-05	0.000262	CcSEcCtD
Oxcarbazepine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.88e-05	0.000261	CcSEcCtD
Oxcarbazepine—CYP3A4—nervous system—acquired immunodeficiency syndrome	4.86e-05	0.0198	CbGeAlD
Oxcarbazepine—Rash—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.000259	CcSEcCtD
Oxcarbazepine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.84e-05	0.000259	CcSEcCtD
Oxcarbazepine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.82e-05	0.000258	CcSEcCtD
Oxcarbazepine—Headache—Ritonavir—acquired immunodeficiency syndrome	4.81e-05	0.000257	CcSEcCtD
Oxcarbazepine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.7e-05	0.000251	CcSEcCtD
Oxcarbazepine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	4.68e-05	0.0191	CbGeAlD
Oxcarbazepine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.66e-05	0.000249	CcSEcCtD
Oxcarbazepine—Rash—Saquinavir—acquired immunodeficiency syndrome	4.66e-05	0.000249	CcSEcCtD
Oxcarbazepine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.65e-05	0.000249	CcSEcCtD
Oxcarbazepine—Headache—Saquinavir—acquired immunodeficiency syndrome	4.63e-05	0.000248	CcSEcCtD
Oxcarbazepine—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.56e-05	0.000244	CcSEcCtD
Oxcarbazepine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.48e-05	0.00024	CcSEcCtD
Oxcarbazepine—Rash—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000238	CcSEcCtD
Oxcarbazepine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.44e-05	0.000238	CcSEcCtD
Oxcarbazepine—Headache—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.000236	CcSEcCtD
Oxcarbazepine—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.39e-05	0.000235	CcSEcCtD
Oxcarbazepine—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.19e-05	0.000224	CcSEcCtD
